SS
Satwant Singh
About Satwant Singh
Data last updated:
Satwant Singh is a Director at Grapple Lifesciences Private Limited (since 2012), Director at Ampira Biotechnics Private Limited (since 2019) and Director at Medlex Biotechnics Private Limited (since 2020), and holds 2 more current directorships. The companies operate in Pharma and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹19.44 Cr; the largest is Grapple Lifesciences Private Limited at ₹8.93 Cr (FY 2025). Earlier, Satwant Singh was a Director at Clabert Lifesciences Private Limited (2018–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Nov 2012 | 2011 | ₹8.93 Cr (FY 2025) | Active | |
| Director | 12 Feb 2019 | 2019 | ₹7.07 Cr (FY 2024) | Active | |
| Director | 16 Dec 2020 | 2020 | ₹3.20 Cr (FY 2024) | Active | |
| Director | 28 Aug 2024 | 2020 | ₹23.6 Lakh (FY 2024) | Active | |
| Director | 16 Dec 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Feb 2018 | 2018 | ₹1.23 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satwant Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay | 07012547 | Grapple Lifesciences Private Limited , Ampira Biotechnics Private Limited and 3 more | Director |
| Babita | 08359360 | Ampira Biotechnics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satwant Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satwant Singh
Satwant Singh currently holds 5 directorships: Grapple Lifesciences Private Limited (Director, since 20 Nov 2012, revenue ₹8.93 Cr (FY 2025)); Ampira Biotechnics Private Limited (Director, since 12 Feb 2019, revenue ₹7.07 Cr (FY 2024)); Medlex Biotechnics Private Limited (Director, since 16 Dec 2020, revenue ₹3.20 Cr (FY 2024)); Livin Herbal Private Limited (Director, since 28 Aug 2024, revenue ₹23.6 Lakh (FY 2024)); Qantas Labs Private Limited (Director, since 16 Dec 2020).
Satwant Singh was first appointed on 20 Nov 2012 as Director at Grapple Lifesciences Private Limited. The most recent appointment on record is 28 Aug 2024 at Livin Herbal Private Limited.
The 4 current companies of Satwant Singh that report revenue have a combined latest revenue of ₹19.44 Cr: Grapple Lifesciences Private Limited ₹8.93 Cr (FY 2025); Ampira Biotechnics Private Limited ₹7.07 Cr (FY 2024); Medlex Biotechnics Private Limited ₹3.20 Cr (FY 2024); Livin Herbal Private Limited ₹23.6 Lakh (FY 2024).
Satwant Singh held 1 earlier board appointment: Clabert Lifesciences Private Limited (Director, 12 Feb 2018 to 29 Dec 2023).